Public Genome Governance

Introduction

Public Genome Governance refers to the legal, ethical, and institutional framework through which governments, research institutions, biotechnology companies, and healthcare organizations regulate genomic science in the public interest. It covers genome sequencing, genetic testing, genome editing, genetic-data collection, and the use of genetically modified organisms.

The concept is not a single codified doctrine. It draws upon constitutional rights, biomedical ethics, environmental law, public-health regulation, and scientific accountability. Its principal objective is to ensure that genomic technologies are developed and used safely, transparently, and fairly, while protecting human dignity, privacy, autonomy, and the interests of future generations.

Legal and Constitutional Framework

In India, Article 21 of the Constitution protects life, personal liberty, dignity, and privacy. Article 14 requires equality and non-arbitrary state action. Article 19 may protect scientific research and expression, subject to constitutional restrictions. Articles 48A and 51A(g) support environmental protection.

Public Genome Governance applies these principles through:

Informed consent: Individuals should understand the purpose, risks, and consequences of genetic testing or intervention.

Genetic privacy: Genomic data should be collected, used, and shared under lawful safeguards.

Biosafety regulation: Genetic technologies should undergo appropriate scientific risk assessment.

Fair access: Genomic healthcare should not create arbitrary discrimination or unjustified exclusion.

Accountability: Regulatory bodies and research institutions should provide reasoned decisions and remain subject to review.

Public participation: Decisions with broad social or environmental effects should include meaningful consultation.

Important Case Laws

1. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognized privacy as a fundamental right under the Constitution, including informational privacy and personal autonomy. It held that interference with privacy must satisfy legality, a legitimate state purpose, and proportionality.

Relevance: Genomic data can reveal sensitive information about health, ancestry, and biological relatives. The judgment supports safeguards against unauthorized collection, disclosure, or misuse of genetic information.

2. Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1

The Court recognized reproductive autonomy as part of personal liberty under Article 21 and emphasized the importance of consent in reproductive decisions.

Relevance: Genetic interventions involving reproduction should respect bodily autonomy and informed choice. This principle is particularly important where interventions may have heritable consequences.

3. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court held that valid medical consent must be voluntary and based on adequate information. Consent to one procedure does not automatically authorize a materially different procedure.

Relevance: Genetic testing and genome editing require clear disclosure of their purpose, risks, limitations, and potential consequences. Consent for clinical testing should not automatically authorize unrelated research or indefinite secondary use of genetic data.

4. Gene Campaign v. Union of India (2024) 2024 INSC 545

The Supreme Court considered challenges to the environmental approval of genetically modified mustard, DMH-11. The Court recognized that regulatory decisions concerning genetically modified organisms are subject to judicial review. It also directed the Union Government to formulate a national policy on GM crops through consultation with relevant stakeholders. The judges differed on the validity of the specific approval, which was referred for further consideration.

SCI API+2

Relevance: The case demonstrates that biotechnology governance requires transparent decision-making, appropriate biosafety review, public consultation, and accountability of regulatory authorities.

Key Principles of Public Genome Governance

Privacy and data protection: Genetic data must be handled under appropriate legal safeguards.

Informed consent: Individuals should understand the purpose, risks, and implications of genetic procedures.

Scientific and ethical review: Genome-related research should be reviewed by competent independent bodies.

Biosafety and precaution: Risks to human health, communities, and the environment should be assessed and monitored.

Equity: Genomic healthcare should not result in unjustified discrimination or unequal access.

Public participation: Decisions with broad social or environmental consequences should include meaningful consultation.

Judicial and regulatory accountability: Authorities must act within law and provide reasoned decisions open to review.

Conclusion

Public Genome Governance seeks to ensure that genomic science advances within a framework of human rights, public welfare, and legal accountability. Although Indian law does not expressly establish a single doctrine under this name, constitutional principles—particularly privacy, autonomy, equality, and environmental protection—provide a strong foundation.

The cases of Puttaswamy, Suchita Srivastava, Samira Kohli, and Gene Campaign offer relevant legal guidance. Together, they support a governance model based on informed consent, genetic privacy, scientific oversight, biosafety, public participation, and judicial review.